Spyre Therapeutics, Inc. (SYRE)

Nasdaq · Healthcare · Biotechnology
$93.47-4.26%As of 2026-11-22 · USD
Last session low $93.22Last session high $99.56
52-week low $24.5852-week high $110.64
Market cap
$8.88B
Sector
Healthcare

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)46.9In the neutral range (30 to 70)
MACD (12, 26, 9)1.76Below its signal line (2.87); histogram -1.10
Bollinger %B (20, 2)13%Inside the bands (91.24 to 108.28)
SMA 2099.76Price is 6.3% below
SMA 5092.29Price is 1.3% above
SMA 20078.28Price is 19.4% above
ATR (20)5.91% of priceAverage true range per day
52-week position80%In the upper part of the 24.58 to 110.64 range

About Spyre Therapeutics, Inc.

Spyre Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD) and rheumatic diseases.

Insider filings, 90 daysNo purchases and 9 sales (about $12.3M).
Latest fiscal yearEnded 2023-12-31: revenue of $886,000 and an operating margin of -14510.6%.

More in Biotechnology